Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Kalaris Therapeutics, Inc. Common Stock

KLRS Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of KLRS by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
KLRS Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
KLRS Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
KLRS Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in KLRS holdings by institutional investors

Quarterly net insider trading by KLRS's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for KLRS

Quiver Logo

No former government officials on record as having lobbied for KLRS

Revolving Door Dashboard

KLRS Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

KLRS Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
KLRS Income Statement
KLRS Balance Sheet
KLRS Cash Flow
U.S. Patents

New KLRS patent grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to KLRS from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
KLRS News

Recent insights relating to KLRS

CNBC Recommendations

Recent picks made for KLRS stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in KLRS

KLRS Analyst Ratings

KLRS Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
KLRS Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $KLRS stock a Buy, Sell, or Hold?

  • What is the price target for $KLRS stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

KLRS Top Shareholders
Shareholder
Shares Held
KLRS Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $KLRS stock?

  • Who owns the most shares of $KLRS stock?

  • What funds own $KLRS stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

KLRS Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view KLRS Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About KLRS

Kalaris Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for prevalent retinal diseases. The company is developing TH103, a novel, clinical-stage anti-vascular endothelial growth factor VEGF drug, engineered to potentially provide longer-lasting and increased anti-VEGF activity in patients with exudative and neovascular retinal diseases. TH103 is a fully humanized recombinant fusion protein, functioning as a decoy receptor (a VEGF trap), leveraging salient molecular properties of the human body's native, highest affinity VEGF receptor 1.

  • Address Berkeley Heights, NJ
  • Market Cap 74.3 million
  • Employees 20
  • Industrial Classification Biological Products, (No Diagnostic Substances)

Kalaris Therapeutics, Inc. Common Stock (KLRS) Historical Stock Prices

Kalaris Therapeutics, Inc. Common Stock (KLRS) closed at $3.12 on September 23, 2026. Over the past year its adjusted close ranged from $3.12 to $10.98. Daily prices go back to January 2, 2014, 1,555 trading days in all.

  • 1 month-23.90%
  • 3 months-29.09%
  • Year to date-63.03%
  • 1 year-34.59%
  • 3 years+36.84%
  • 5 years-86.49%
  • Max+367.14%
See every congressional and insider trade on the KLRS price chart

Quiver Premium charts KLRS's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 3.20 3.21 3.12 3.12 3.12 24,129
Sep 22, 2026 3.23 3.29 3.16 3.24 3.24 29,135
Sep 21, 2026 3.20 3.30 3.09 3.25 3.25 88,631
Sep 18, 2026 3.18 3.23 3.04 3.20 3.20 234,394
Sep 17, 2026 3.20 3.27 3.13 3.16 3.16 43,336
Sep 16, 2026 3.15 3.25 3.10 3.18 3.18 61,745
Sep 15, 2026 3.35 3.35 3.20 3.20 3.20 109,362
Sep 14, 2026 3.41 3.44 3.25 3.30 3.30 57,632
Sep 11, 2026 3.39 3.44 3.27 3.38 3.38 95,102
Sep 10, 2026 3.55 3.66 3.30 3.30 3.30 60,821
Sep 9, 2026 3.66 3.68 3.45 3.47 3.47 82,984
Sep 8, 2026 3.88 3.90 3.60 3.63 3.63 100,721
Sep 4, 2026 3.91 3.95 3.82 3.90 3.90 23,861
Sep 3, 2026 3.97 4.04 3.90 3.94 3.94 39,986
Sep 2, 2026 3.97 4.13 3.90 3.90 3.90 17,271
Sep 1, 2026 3.96 4.00 3.86 3.92 3.92 62,331
Aug 31, 2026 3.99 4.04 3.83 4.04 4.04 19,587
Aug 28, 2026 4.12 4.15 3.89 4.03 4.03 52,613
Aug 27, 2026 4.08 4.19 4.00 4.10 4.10 104,887
Aug 26, 2026 4.24 4.31 3.99 4.08 4.08 28,247
Aug 25, 2026 4.04 4.25 4.04 4.20 4.20 26,261
Aug 24, 2026 4.13 4.19 3.94 4.10 4.10 51,385
Aug 21, 2026 4.10 4.30 3.99 4.15 4.15 81,244
Aug 20, 2026 4.20 4.20 3.97 4.12 4.12 50,214
Aug 19, 2026 4.10 4.33 3.98 4.17 4.17 79,551
Aug 18, 2026 4.00 4.20 3.89 4.03 4.03 29,575
Aug 17, 2026 4.05 4.17 3.91 3.96 3.96 30,096
Aug 14, 2026 4.02 4.15 3.88 4.08 4.08 28,090
Aug 13, 2026 3.92 4.06 3.84 3.88 3.88 56,523
Aug 12, 2026 4.07 4.18 3.94 3.94 3.94 62,194
Aug 11, 2026 3.95 4.14 3.94 3.97 3.97 27,605
Aug 10, 2026 4.14 4.17 3.89 3.94 3.94 40,095
Aug 7, 2026 4.27 4.31 4.04 4.07 4.07 58,832
Aug 6, 2026 4.19 4.30 4.09 4.19 4.19 55,619
Aug 5, 2026 4.32 4.38 4.06 4.19 4.19 26,401
Aug 4, 2026 4.02 4.40 4.02 4.32 4.32 133,652
Aug 3, 2026 3.57 4.08 3.46 4.05 4.05 156,594
Jul 31, 2026 3.43 3.61 3.40 3.51 3.51 71,946
Jul 30, 2026 3.37 3.51 3.03 3.48 3.48 76,285
Jul 29, 2026 3.32 3.46 3.23 3.40 3.40 100,018
Jul 28, 2026 3.62 3.69 3.27 3.34 3.34 118,282
Jul 27, 2026 3.75 3.84 3.50 3.58 3.58 71,675
Jul 24, 2026 3.87 3.96 3.52 3.73 3.73 157,758
Jul 23, 2026 3.93 4.19 3.82 3.92 3.92 137,697
Jul 22, 2026 4.00 4.10 3.91 4.07 4.07 97,362
Jul 21, 2026 3.95 4.05 3.53 4.04 4.04 395,381
Jul 20, 2026 4.25 4.59 3.95 4.00 4.00 498,427
Jul 17, 2026 4.43 6.25 4.30 4.38 4.38 10,944,040
Jul 16, 2026 4.77 4.77 4.42 4.61 4.61 61,346
Jul 15, 2026 4.58 4.88 4.40 4.82 4.82 74,362
Jul 14, 2026 4.43 4.62 4.30 4.55 4.55 35,440
Jul 13, 2026 4.41 4.50 4.24 4.42 4.42 68,022
Jul 10, 2026 4.54 4.54 4.33 4.44 4.44 10,279
Jul 9, 2026 4.73 4.73 4.46 4.49 4.49 16,083
Jul 8, 2026 4.88 4.92 4.47 4.71 4.71 64,589
Jul 7, 2026 4.80 4.83 4.61 4.83 4.83 22,463
Jul 6, 2026 4.76 4.91 4.57 4.65 4.65 49,656
Jul 2, 2026 4.55 4.79 4.38 4.75 4.75 56,292
Jul 1, 2026 4.33 4.60 4.15 4.53 4.53 54,458
Jun 30, 2026 4.24 4.34 3.90 4.07 4.07 104,018
Jun 29, 2026 4.28 4.38 4.16 4.21 4.21 122,083
Jun 26, 2026 4.43 4.49 4.25 4.32 4.32 164,531
Jun 25, 2026 4.37 4.59 4.23 4.30 4.30 53,178
Jun 24, 2026 4.49 4.61 4.25 4.40 4.40 50,566
Jun 23, 2026 4.38 4.54 4.31 4.47 4.47 22,095
Jun 22, 2026 4.68 4.70 4.39 4.40 4.40 66,297
Jun 18, 2026 4.57 4.80 4.55 4.72 4.72 235,547
Jun 17, 2026 4.69 4.75 4.46 4.55 4.55 82,457
Jun 16, 2026 4.42 4.57 4.29 4.37 4.37 45,120
Jun 15, 2026 4.54 4.65 4.27 4.27 4.27 83,946
Jun 12, 2026 4.38 4.68 4.28 4.33 4.33 34,256
Jun 11, 2026 4.16 4.42 4.10 4.36 4.36 60,022
Jun 10, 2026 4.06 4.26 4.04 4.16 4.16 47,848
Jun 9, 2026 4.26 4.26 4.02 4.08 4.08 103,686
Jun 8, 2026 4.44 4.54 4.15 4.17 4.17 57,922
Jun 5, 2026 4.66 4.66 4.40 4.44 4.44 141,445
Jun 4, 2026 4.72 4.83 4.66 4.66 4.66 39,549
Jun 3, 2026 4.66 4.97 4.66 4.72 4.72 45,596
Jun 2, 2026 4.92 4.92 4.56 4.65 4.65 99,783
Jun 1, 2026 5.26 5.28 4.85 4.90 4.90 65,416
May 29, 2026 5.21 5.38 5.11 5.27 5.27 145,027
May 28, 2026 5.24 5.60 5.09 5.18 5.18 40,070
May 27, 2026 5.30 5.44 5.05 5.24 5.24 82,205
May 26, 2026 5.48 5.60 5.16 5.21 5.21 156,115
May 22, 2026 5.08 5.22 4.71 4.92 4.92 88,981
May 21, 2026 4.75 5.15 4.75 5.12 5.12 34,162
May 20, 2026 4.67 4.91 4.56 4.83 4.83 53,234
May 19, 2026 4.61 4.84 4.61 4.70 4.70 21,311
May 18, 2026 4.89 5.05 4.52 4.74 4.74 85,307
May 15, 2026 5.29 5.29 4.89 4.90 4.90 33,842
May 14, 2026 4.90 5.39 4.83 5.22 5.22 171,890
May 13, 2026 4.66 4.91 4.52 4.83 4.83 119,522
May 12, 2026 4.74 4.83 4.52 4.79 4.79 163,023
May 11, 2026 5.02 5.05 4.69 4.73 4.73 155,342
May 8, 2026 5.17 5.24 4.99 5.08 5.08 41,395
May 7, 2026 5.06 5.18 4.96 5.15 5.15 103,176
May 6, 2026 5.36 5.37 5.06 5.06 5.06 106,150
May 5, 2026 5.51 5.62 5.20 5.30 5.30 109,556
May 4, 2026 5.49 5.67 5.44 5.53 5.53 54,809
May 1, 2026 5.53 5.71 5.44 5.46 5.46 86,148
Apr 30, 2026 5.67 5.73 5.44 5.52 5.52 217,171
Apr 29, 2026 5.65 5.75 5.45 5.51 5.51 91,720
Apr 28, 2026 6.00 6.03 5.48 5.63 5.63 153,194
Apr 27, 2026 6.09 6.13 6.02 6.02 6.02 17,600
Apr 24, 2026 6.07 6.26 6.05 6.11 6.11 26,444
Apr 23, 2026 6.33 6.49 6.00 6.10 6.10 32,916
Apr 22, 2026 6.27 6.62 6.20 6.33 6.33 53,718
Apr 21, 2026 6.54 6.61 6.24 6.28 6.28 46,948
Apr 20, 2026 6.20 6.68 6.14 6.60 6.60 96,186
Apr 17, 2026 6.68 6.68 6.11 6.32 6.32 106,003
Apr 16, 2026 6.06 6.68 6.00 6.59 6.59 180,022
Apr 15, 2026 5.79 5.99 5.42 5.87 5.87 166,328
Apr 14, 2026 6.29 6.37 5.66 5.82 5.82 140,255
Apr 13, 2026 6.16 6.46 6.03 6.31 6.31 40,008
Apr 10, 2026 5.86 6.38 5.78 6.30 6.30 63,402
Apr 9, 2026 6.40 6.64 5.83 6.07 6.07 67,533
Apr 8, 2026 6.73 7.14 6.23 6.34 6.34 114,341
Apr 7, 2026 6.24 6.75 6.11 6.46 6.46 124,344
Apr 6, 2026 5.84 6.32 5.83 6.27 6.27 129,854
Apr 2, 2026 5.75 6.09 5.53 5.79 5.79 23,572
Apr 1, 2026 6.18 6.18 5.66 5.93 5.93 38,416
Mar 31, 2026 5.25 6.18 5.25 5.77 5.77 58,295
Mar 30, 2026 5.43 5.66 5.24 5.30 5.30 25,864
Mar 27, 2026 5.86 5.99 5.24 5.39 5.39 173,422
Mar 26, 2026 5.98 6.16 5.68 5.82 5.82 100,595
Mar 25, 2026 6.24 6.70 5.96 6.12 6.12 60,449
Mar 24, 2026 6.50 6.81 6.20 6.20 6.20 44,270
Mar 23, 2026 6.65 6.85 6.46 6.50 6.50 41,026
Mar 20, 2026 6.72 6.92 6.55 6.57 6.57 57,900
Mar 19, 2026 7.53 7.60 6.72 6.81 6.81 76,246
Mar 18, 2026 8.50 8.62 7.53 7.53 7.53 63,324
Mar 17, 2026 8.81 9.29 8.08 8.52 8.52 51,272
Mar 16, 2026 8.96 8.96 8.20 8.81 8.81 84,753
Mar 13, 2026 9.05 9.07 8.55 8.67 8.67 32,467
Mar 12, 2026 9.35 9.56 8.67 9.17 9.17 86,451
Mar 11, 2026 9.96 9.96 9.13 9.21 9.21 31,729
Mar 10, 2026 9.82 10.00 9.48 9.96 9.96 31,819
Mar 9, 2026 9.65 10.19 9.30 10.00 10.00 44,725
Mar 6, 2026 9.46 10.42 9.35 9.82 9.82 41,326
Mar 5, 2026 9.31 9.75 8.85 9.68 9.68 52,750
Mar 4, 2026 9.50 10.09 8.85 9.08 9.08 55,884
Mar 3, 2026 9.97 10.56 9.26 9.42 9.42 71,094
Mar 2, 2026 10.19 10.69 10.10 10.42 10.42 28,472
Feb 27, 2026 10.39 10.65 10.10 10.46 10.46 27,104
Feb 26, 2026 10.56 10.80 10.31 10.56 10.56 14,441
Feb 25, 2026 11.00 11.02 9.90 10.63 10.63 58,868
Feb 24, 2026 10.67 11.21 10.54 10.97 10.97 43,781
Feb 23, 2026 10.50 11.02 9.81 10.77 10.77 104,279
Feb 20, 2026 11.04 11.04 9.96 10.00 10.00 81,276
Feb 19, 2026 10.23 11.02 10.00 10.98 10.98 92,294
Feb 18, 2026 8.48 10.43 8.48 10.24 10.24 144,585
Feb 17, 2026 9.96 9.96 8.08 8.27 8.27 176,659
Feb 13, 2026 9.02 9.27 8.54 8.65 8.65 27,708
Feb 12, 2026 9.63 9.90 8.80 8.98 8.98 53,994
Feb 11, 2026 10.14 10.28 8.85 9.64 9.64 60,256
Feb 10, 2026 9.05 10.27 8.92 10.02 10.02 79,259
Feb 9, 2026 8.35 9.29 8.34 9.05 9.05 57,114
Feb 6, 2026 8.37 8.75 8.29 8.34 8.34 44,325
Feb 5, 2026 8.89 8.89 8.25 8.35 8.35 39,245
Feb 4, 2026 9.07 9.35 8.41 8.83 8.83 36,615
Feb 3, 2026 9.15 9.48 9.06 9.14 9.14 57,208
Feb 2, 2026 8.75 9.15 8.75 9.11 9.11 15,977
Jan 30, 2026 9.01 9.33 8.80 8.88 8.88 43,069
Jan 29, 2026 9.41 9.61 9.09 9.20 9.20 17,080
Jan 28, 2026 9.61 9.70 8.78 9.45 9.45 76,266
Jan 27, 2026 9.79 10.47 9.61 9.61 9.61 63,647
Jan 26, 2026 9.85 9.88 9.55 9.85 9.85 46,234
Jan 23, 2026 9.84 9.88 9.62 9.80 9.80 37,085
Jan 22, 2026 9.89 9.96 9.12 9.78 9.78 32,473
Jan 21, 2026 9.81 10.00 9.76 9.79 9.79 29,543
Jan 20, 2026 9.56 9.99 9.04 9.81 9.81 62,878
Jan 16, 2026 8.70 9.96 8.60 9.74 9.74 111,533
Jan 15, 2026 9.16 9.37 8.80 8.86 8.86 89,402
Jan 14, 2026 9.35 9.39 8.74 9.24 9.24 45,852
Jan 13, 2026 8.85 9.46 8.69 9.24 9.24 47,636
Jan 12, 2026 9.76 9.97 8.72 8.84 8.84 174,126
Jan 9, 2026 8.37 10.24 8.30 9.78 9.78 238,591
Jan 8, 2026 8.82 8.96 8.26 8.26 8.26 45,261
Jan 7, 2026 8.53 9.09 8.40 8.76 8.76 86,810
Jan 6, 2026 8.14 8.42 8.03 8.26 8.26 83,665
Jan 5, 2026 8.43 8.88 7.92 8.18 8.18 109,107
Jan 2, 2026 8.42 8.53 8.04 8.30 8.30 94,015
Dec 31, 2025 8.38 8.88 8.31 8.44 8.44 119,376
Dec 30, 2025 9.09 9.45 8.32 8.38 8.38 95,949
Dec 29, 2025 9.15 9.34 8.41 9.13 9.13 101,315
Dec 26, 2025 10.20 10.20 9.12 9.26 9.26 91,729
Dec 24, 2025 9.66 9.72 9.39 9.58 9.58 19,666
Dec 23, 2025 10.11 11.00 9.51 9.66 9.66 101,659
Dec 22, 2025 9.18 10.23 9.18 10.06 10.06 109,149
Dec 19, 2025 10.36 10.50 9.00 9.13 9.13 251,588
Dec 18, 2025 10.84 11.88 9.98 10.42 10.42 636,346
Dec 17, 2025 8.65 10.98 8.30 10.42 10.42 737,244
Dec 16, 2025 8.45 8.84 8.30 8.66 8.66 86,455
Dec 15, 2025 8.89 8.95 8.29 8.50 8.50 93,068
Dec 12, 2025 8.45 8.87 7.82 8.87 8.87 187,241
Dec 11, 2025 7.57 8.61 7.45 8.33 8.33 154,293
Dec 10, 2025 7.11 7.70 7.10 7.57 7.57 128,987
Dec 9, 2025 6.17 7.60 6.17 7.12 7.12 299,503
Dec 8, 2025 5.92 6.25 5.58 6.16 6.16 48,767
Dec 5, 2025 5.87 6.26 5.82 5.88 5.88 34,298
Dec 4, 2025 5.54 6.00 5.33 5.92 5.92 210,203
Dec 3, 2025 5.48 5.60 5.35 5.54 5.54 147,463
Dec 2, 2025 5.47 5.80 5.10 5.47 5.47 178,516
Dec 1, 2025 5.97 6.11 5.40 5.45 5.45 137,895
Nov 28, 2025 6.54 6.54 5.66 6.24 6.24 116,661
Nov 26, 2025 6.36 6.54 6.07 6.44 6.44 46,749
Nov 25, 2025 6.50 6.76 6.10 6.26 6.26 87,335
Nov 24, 2025 7.07 7.07 6.37 6.45 6.45 107,614
Nov 21, 2025 6.91 7.07 6.04 7.01 7.01 198,481
Nov 20, 2025 6.93 7.14 6.54 6.90 6.90 349,131
Nov 19, 2025 6.45 6.98 6.08 6.68 6.68 470,108
Nov 18, 2025 5.49 6.49 5.23 6.45 6.45 291,686
Nov 17, 2025 5.47 5.67 5.31 5.42 5.42 108,375
Nov 14, 2025 5.10 5.49 5.00 5.46 5.46 48,448
Nov 13, 2025 4.87 5.45 4.87 5.33 5.33 79,240
Nov 12, 2025 4.86 5.11 4.73 4.96 4.96 124,888
Nov 11, 2025 4.84 5.24 4.84 5.07 5.07 97,888
Nov 10, 2025 4.75 5.07 4.50 4.80 4.80 122,217
Nov 7, 2025 4.69 4.83 4.51 4.75 4.75 294,454
Nov 6, 2025 5.00 5.15 4.54 4.73 4.73 203,735
Nov 5, 2025 4.73 5.03 4.70 5.00 5.00 118,697
Nov 4, 2025 4.82 4.99 4.67 4.71 4.71 45,288
Nov 3, 2025 5.08 5.45 4.78 4.99 4.99 108,637
Oct 31, 2025 4.76 5.12 4.71 5.03 5.03 49,360
Oct 30, 2025 4.82 4.92 4.70 4.74 4.74 25,220
Oct 29, 2025 4.98 5.24 4.71 4.87 4.87 42,618
Oct 28, 2025 4.90 5.30 4.71 5.00 5.00 145,717
Oct 27, 2025 4.76 4.96 4.60 4.86 4.86 68,559
Oct 24, 2025 4.85 4.98 4.75 4.77 4.77 42,286
Oct 23, 2025 4.41 5.05 4.40 4.89 4.89 110,569
Oct 22, 2025 4.70 4.70 4.27 4.38 4.38 97,001
Oct 21, 2025 4.90 4.98 4.64 4.73 4.73 68,285
Oct 20, 2025 4.52 5.07 4.52 4.90 4.90 118,865
Oct 17, 2025 4.83 4.91 4.50 4.63 4.63 81,005
Oct 16, 2025 4.91 5.00 4.74 4.79 4.79 76,659
Oct 15, 2025 5.12 5.24 4.73 4.93 4.93 87,633
Oct 14, 2025 4.84 5.24 4.64 5.10 5.10 127,133
Oct 13, 2025 4.45 4.98 4.29 4.76 4.76 286,160
Oct 10, 2025 4.70 4.90 4.35 4.45 4.45 369,873
Oct 9, 2025 6.54 6.66 4.34 4.62 4.62 601,614
Oct 8, 2025 7.76 8.21 6.50 6.59 6.59 199,486
Oct 7, 2025 7.97 8.45 6.98 7.72 7.72 329,336
Oct 6, 2025 6.64 8.80 6.64 8.03 8.03 524,748
Oct 3, 2025 7.00 7.31 6.62 6.64 6.64 113,243
Oct 2, 2025 6.08 7.62 6.08 7.09 7.09 371,132
Oct 1, 2025 5.78 6.70 5.78 6.07 6.07 130,242
Sep 30, 2025 6.30 6.79 5.75 5.78 5.78 221,953
Sep 29, 2025 5.75 6.45 5.53 6.35 6.35 219,518
Sep 26, 2025 4.77 5.80 4.75 5.61 5.61 251,447
Sep 25, 2025 4.53 4.81 4.41 4.77 4.77 80,754
Sep 24, 2025 4.79 4.93 4.45 4.53 4.53 139,134
Sep 23, 2025 4.44 4.82 4.37 4.77 4.77 143,069

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Kalaris Therapeutics, Inc. Common Stock Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at KLRS, per a recent SEC DEF 14A filing.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation